Blair William & Co. IL lifted its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,814,195 shares of the company's stock after acquiring an additional 29,279 shares during the quarter. Blair William & Co. IL owned 1.07% of Ryan Specialty worth $191,337,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Ryan Specialty by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 10,271,428 shares of the company's stock worth $758,750,000 after purchasing an additional 390,924 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Ryan Specialty by 66.4% in the first quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock worth $225,404,000 after acquiring an additional 1,218,147 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Ryan Specialty by 0.5% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,378,573 shares of the company's stock valued at $175,706,000 after acquiring an additional 12,573 shares during the period. Stephens Investment Management Group LLC lifted its position in shares of Ryan Specialty by 2.2% in the 1st quarter. Stephens Investment Management Group LLC now owns 1,642,527 shares of the company's stock valued at $121,333,000 after acquiring an additional 34,932 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in Ryan Specialty by 121.6% in the 1st quarter. Invesco Ltd. now owns 1,590,862 shares of the company's stock worth $117,517,000 after purchasing an additional 872,846 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts have issued reports on RYAN shares. Wells Fargo & Company boosted their target price on shares of Ryan Specialty from $60.00 to $64.00 and gave the company an "overweight" rating in a research note on Wednesday. Citigroup began coverage on Ryan Specialty in a research report on Wednesday, August 13th. They set a "buy" rating and a $74.00 price target on the stock. Weiss Ratings restated a "hold (c-)" rating on shares of Ryan Specialty in a research report on Wednesday. UBS Group dropped their target price on Ryan Specialty from $80.00 to $75.00 and set a "buy" rating on the stock in a report on Wednesday. Finally, Barclays reissued an "overweight" rating and issued a $70.00 price target on shares of Ryan Specialty in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $72.83.
Get Our Latest Stock Analysis on Ryan Specialty
Insider Activity
In other Ryan Specialty news, Chairman Patrick G. Ryan acquired 276,634 shares of the firm's stock in a transaction that occurred on Friday, September 12th. The stock was purchased at an average cost of $51.84 per share, for a total transaction of $14,340,706.56. Following the completion of the acquisition, the chairman owned 13,699,959 shares of the company's stock, valued at approximately $710,205,874.56. This trade represents a 2.06% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 52.21% of the company's stock.
Ryan Specialty Stock Performance
Shares of RYAN stock opened at $58.26 on Thursday. Ryan Specialty Holdings Inc. has a fifty-two week low of $50.08 and a fifty-two week high of $77.16. The stock's 50-day moving average is $56.44 and its two-hundred day moving average is $64.25. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market cap of $15.36 billion, a P/E ratio of 166.46, a PEG ratio of 1.62 and a beta of 0.63.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.66 EPS for the quarter, meeting the consensus estimate of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The business had revenue of $855.17 million during the quarter, compared to analysts' expectations of $837.52 million. During the same quarter in the previous year, the business posted $0.58 EPS. The firm's quarterly revenue was up 23.0% compared to the same quarter last year. Analysts predict that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 26th. Stockholders of record on Tuesday, August 12th were issued a dividend of $0.12 per share. The ex-dividend date was Tuesday, August 12th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.8%. Ryan Specialty's dividend payout ratio (DPR) is currently 137.14%.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report